| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/17/2007 | CN1895268A Externally-applied medicine with burn, ambustion and insult treatment and its preparation |
| 01/17/2007 | CN1895224A Polyvinyl-phosphorylcholine elaioplast preparation and its making method |
| 01/17/2007 | CN1895210A Aloe melt glue and active synergistic alimentary cosmetic liquid |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1294990C Composition of nanometer SOD and ginseng or its extract and its preparation method |
| 01/17/2007 | CN1294989C Composition of nanometer SOD and nano pueraria root and its preparation method |
| 01/17/2007 | CN1294986C Process for producing ampeptide element |
| 01/17/2007 | CN1294982C Medication for curing alopecia |
| 01/17/2007 | CN1294978C Composition for dispelling spot and its preparation method |
| 01/17/2007 | CN1294965C Medicine for tissue-regeneration skin-grafting |
| 01/17/2007 | CN1294964C Composite Chinese medicinal prescription for breeding and blackening hair and preparation method therefor |
| 01/17/2007 | CN1294956C Oral compositions for the treatment of scalp disorders |
| 01/17/2007 | CN1294953C External Chinese materia medica preparation for treating leucoderma |
| 01/17/2007 | CN1294947C Pill for treating alopecia |
| 01/17/2007 | CN1294945C Traditional Chinese medicine ointment for treating burns and scald |
| 01/17/2007 | CN1294938C Skin inflammation eliminating tincture |
| 01/17/2007 | CN1294937C Chinese medicine preparation for treating bromhidrosis |
| 01/17/2007 | CN1294916C Pernio ointment for treating itch and pain |
| 01/17/2007 | CN1294915C Eliminating stasis and tissue generation toxic removing pill |
| 01/17/2007 | CN1294913C Medication combination of containing finasteride and cyclodextrin or ramification |
| 01/17/2007 | CN1294909C Novel anti-biological cell free-radical oxidation injury mixture |
| 01/17/2007 | CN1294905C Drug composition for treating osteoporosis |
| 01/17/2007 | CN1294899C Black soya bean oil contained compound gelling agent |
| 01/17/2007 | CN1294896C Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164024 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 01/16/2007 | US7163960 Treatment and prevention of inflammatory disorders |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163930 Pharmaceutical compositions and methods relating to fucans |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | CA2366065C Topical cosmetic composition comprising bifidobacterium and plant extracellular matrix |
| 01/16/2007 | CA2294482C Treatment of aging skin |
| 01/16/2007 | CA2266763C Use of at least one hydroxystilbene in a composition designed to encourage exfoliation of the skin, and composition containing it |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007004337A1 White hair development model animal, method for establishing white hair development model animal, method for passage of white hair development model animal, method for study on white hair development, screening method for white hair development-control means, and composition for control of white hair development |
| 01/11/2007 | WO2007003915A1 Composition for dermatological treatment |
| 01/11/2007 | WO2007003773A2 Use of a yeast extract in the form of an active agent for inducing a synthesis of sirt proteins in skin cells |
| 01/11/2007 | WO2007003307A1 Agent containing l-carnitine or l-carnitine derivatives and at least one other specific substance |
| 01/11/2007 | WO2006124780A3 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
| 01/11/2007 | WO2006123226A3 An inhibitor of mtor for inhibiting the formation of scar tissue |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010430 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2007 | US20070009951 Gene expression vaccine |
| 01/11/2007 | US20070009611 Treatment of wounds and compositions employed |
| 01/11/2007 | US20070009469 Treatment of skin, and wound repair, with thymosin beta 4 |
| 01/11/2007 | US20070009451 Cosmetic and/or pharmaceutical compositions for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 01/11/2007 | DE102005031575A1 Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Förderung der Wundheilung Use of activators of soluble guanylate cyclase to promote wound healing |
| 01/11/2007 | DE102005031362A1 Composition, useful as sun protecting agent, comprises a silicate layer containing an iron raw material on one side and biomass and/or an extract of terrestrial fungus on the other side |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/10/2007 | EP1741780A2 High affinity oligonucleotide ligands to growth factors |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741719A1 Epithelial cell growth promoter |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741436A1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740591A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 01/10/2007 | EP1740548A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes |
| 01/10/2007 | EP1740149A1 Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and a polymer containing said monomer compound and the use thereof |
| 01/10/2007 | EP1740144A2 Phototherapy systems and methods |
| 01/10/2007 | EP1507524B1 Topical use of diuretics for treating swellings |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1893940A Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof |
| 01/10/2007 | CN1891284A Chinese medicine composition, and its preparing method and quality control method |
| 01/10/2007 | CN1891270A Burn-empyrosis-wound-sore oil, and its compounding method and use |
| 01/10/2007 | CN1891261A Ointment for treating burn and empyrosis, and its preparing method |
| 01/10/2007 | CN1891259A External-use Chinese medicine preparation for treating bromhidrosis |
| 01/10/2007 | CN1891245A Centella soft capsule and its preparing method |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293907C Health product for improving skin moisture content and preparation method thereof |
| 01/10/2007 | CN1293897C Burn- and scald-treating powder |
| 01/10/2007 | CN1293885C High-permeability burn-treating preparation |
| 01/10/2007 | CN1293883C Beautifying liquid and preparation method thereof |
| 01/10/2007 | CN1293880C Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/10/2007 | CN1293875C Cell growth regulating factor S and its preparation process |
| 01/10/2007 | CN1293873C Andrographis herb preparation |
| 01/10/2007 | CN1293871C Wild apple polyphenol and process for producing the same |
| 01/09/2007 | US7160981 Peptide antagonists of DP transcription factors |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |